Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

322.18
Data as of Jul 30
 +17.67 / +5.80%
Today’s Change
227.64
Today|||52-Week Range
352.49
+17.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$32.5B

Company Description

Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis. The company's products include EYLEA (aflibercept) injection, which is used for the treatment of neovascular age related macular degeneration; ARCALYST (rilonacept), which is used for the treatment of Cryopyrin-Associated Periodic Syndrome, including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome; and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia. The company was founded by Alferd G. Gilman, Leonard S. Schleifer and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Contact Information

Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown New York 10591-6707
P:(914) 847-7000
Investor Relations:
(914) 847-7799

Employees

Shareholders

Mutual fund holders44.76%
Other institutional30.52%
Individual stakeholders25.00%

Top Executives

Leonard S. SchleiferPresident, Chief Executive Officer & Director
Robert E. LandryChief Financial Officer
George Damis YancopoulosDirector & Chief Scientific Officer
Neil StahlSenior VP-Research & Development Sciences
William G. RobertsVP-Regulatory Development & Medical Safety

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.